Brief: Ascelia Pharma Presents Results Of Orviglance Food Effect Study At RSNA 2022

Ascelia Pharma AB

30/11/2022 07:10

Nov 30 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * ASCELIA PHARMA PRESENTS RESULTS OF ORVIGLANCE FOOD EFFECT
STUDY
AT RSNA 2022 SHOWING STRONG LIVER ENHANCEMENT BOTH WITH LIGHT
MEAL AND IN FASTING CONDITION
    * FOOD EFFECT STUDY RESULTS SHOW THAT INTAKE OF A LIGHT MEAL
WITHIN 30 MIN PRIOR TO ORVIGLANCE ADMINISTRATION PROVIDES
SIMILAR IMAGE MRI ENHANCEMENT OF LIVER COMPARED TO A FASTING
CONDITION
    * IN LINE WITH PREVIOUS STUDIES, DATA ALSO CONFIRMS STRONG
IMAGE
ENHANCEMENT OF LIVER AFTER ORVIGLANCE ADMINISTRATION COMPARED TO
AN MRI IMAGE WITHOUT A CONTRAST AGENT

Source text for Eikon:  ID:nMFN6YzPRV 
Further company coverage:  ACELP.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))